Community Oncology Alliance Executive Director Okon Testifies Before House Oversight & Government Reform Subcommittee
October 05, 2026
October 05, 2026
WASHINGTON, Oct. 5 -- The House Oversight and Government Reform Subcommittee on Health Care and Financial Services released the following written testimony by Ted Okon, executive director of the Community Oncology Alliance, from a Sept. 15, 2026, hearing entitled "Unequal Treatment: Addressing the Drivers of Unaffordability for Oral Chemotherapy":
* * *
A cancer patient should not pay more--or wait longer--for a cancer drug simply because the medicine comes in . . .
* * *
A cancer patient should not pay more--or wait longer--for a cancer drug simply because the medicine comes in . . .